ARMK Form 4: Executive Credited 29.385 Dividend-Equivalent Shares

Rhea-AI Filing Summary

Aramark (ARMK) Form 4: Christopher T. Schilling, SVP, Controller and CAO, was credited with 29.385 dividend-equivalent shares on 08/20/2025 relating to restricted stock units; the shares were recorded at $0 and increased his reported beneficial ownership to 33,450.931 shares (direct). The filing states these dividend-equivalent rights accrued from the company’s quarterly dividend and vest on the same schedules as the underlying restricted stock units. The form was signed by an attorney-in-fact on 08/21/2025.

Positive

• Received 29.385 dividend-equivalent shares tied to restricted stock units, increasing direct ownership to 33,450.931 shares
• Disclosure clarifies these are dividend-equivalent rights that vest on the same schedule as the underlying awards, aiding transparency

Negative

• None.

Insights

Financial Analyst

TL;DR: A routine, non-cash credit of dividend-equivalent shares to an executive increases direct ownership marginally.

The transaction is an administrative credit of dividend-equivalent rights tied to restricted stock units rather than an open-market purchase or sale. Reporting shows 29.385 shares credited at $0, raising direct beneficial ownership to 33,450.931 shares. This has limited immediate liquidity or valuation implications because it reflects dividend accruals on RSUs and vests per existing schedules.

Corporate Governance Expert

TL;DR: Disclosure aligns with standard Section 16 reporting for equity-based compensation; no governance red flags.

The Form 4 discloses dividend-equivalent accruals on RSUs for an officer, with clear explanation that such rights vest with the underlying awards. The form is signed by an attorney-in-fact and filed timely following the 08/20/2025 transaction date, indicating compliance with filing requirements. No indications of unusual related-party transactions appear in this filing.

Insider Trade Summary

Grant/Award: 29.385 shares

Grant/Award 1 txn

Insider Schilling Christopher T.

Role SVP, Controller and CAO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	29.385	$0.00	$0.00

Holdings After Transaction: Common Stock — 33,450.931 shares (Direct)

Footnotes (1)

1. F1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on restricted stock units. These dividend equivalent rights vest on the same schedules as the underlying awards.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Christopher T. Schilling report on the ARMK Form 4?

He reported an acquisition of 29.385 dividend-equivalent shares on 08/20/2025, increasing direct beneficial ownership to 33,450.931 shares.

Were the shares purchased on the open market according to the Form 4?

No. The filing states these are dividend-equivalent rights credited in connection with restricted stock units and recorded at $0.

What is the nature of the dividend-equivalent rights disclosed?

They accrued from the issuer’s quarterly dividend and vest on the same schedules as the underlying restricted stock units.

When was the Form 4 signed and filed?

The signature block shows the form was signed by an attorney-in-fact on 08/21/2025, reflecting the 08/20/2025 transaction.

Does the Form 4 show any sales or disposals by the reporting person?

No. The filing reports an acquisition (A) of dividend-equivalent rights and lists resulting beneficial ownership; no disposals are reported.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/21/2025 - 04:40 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schilling Christopher T.

(Last) (First) (Middle)

ARAMARK

2400 MARKET STREET

(Street)

PHILADELPHIA PA 19103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Controller and CAO

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/20/2025		A		29.385(1)	A	$0	33,450.931	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on restricted stock units. These dividend equivalent rights vest on the same schedules as the underlying awards.

Remarks:

	/s/ Ryan S. Spengler, as Attorney-in-fact	08/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.